Fiducial marker–guided microwave ablation of liver tumors occult on conventional ablation-guidance imaging: A prospective single-center technical feasibility study

Backgrounds/Aims: Some liver tumors are visible on dynamic magnetic resonance imaging (MRI) yet remain occult on ultrasound (US), non-enhanced computed tomography (CT), US-CT/MRI fusion imaging, and contrast-enhanced US, which precludes image-guided ablation. We report a prospective single-center feasibility study of percutaneous gold fiducial tagging undertaken to enable microwave ablation (MWA) of such lesions. Methods: Of 168 patients (204 lesions) referred for hepatic ablation between January 2024 and March 2025, 25 lesions in 20 patients were occult on all four modalities and were enrolled. A single gold fiducial was implanted under US guidance one day before ablation using MRI-derived anatomic landmarks. Post-placement imaging characterized the three-dimensional fiducial-to-lesion offset and thereby provided a calibrated targeting vector for MWA. Technical success was defined as complete lesion coverage with a ≥ 5 mm circumferential margin on post-procedure imaging. Results: All 25 fiducials were placed without complications (median fiducial-to-lesion distance 8 mm, range 2-19). MWA was technically successful in 25 of 25 lesions (100%), and an independently confirmed ≥ 5 mm margin was achieved in every case. No procedure-related complications occurred and no local tumor progression was detected over a median follow-up of 21 months (range 12-30). Conclusions: Percutaneous gold fiducial tagging with vector-guided MWA is a feasible and reproducible strategy for ablating liver tumors that are occult on conventional planning modalities, achieving high targeting reproducibility and early local control in a selected cohort.

Authors

Institutions

Publication Details

Journal
Annals of Hepato-Biliary-Pancreatic Surgery
Published
2026-11-13
DOI
https://doi.org/10.14701/ahbps.26-185
Primary Topic
Hepatocellular Carcinoma Treatment and Prognosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Fiducial marker–guided microwave ablation of liver tumors occult on conventional ablation-guidance imaging: A prospective single-center technical feasibility study

Soumil Singhal, S K Yadav, Sanjay Saran Baijal, Anubhav Harish Khandelwal et al.
3 links
Annals of Hepato-Biliary-Pancreatic Surgery
Hepatocellular Carcinoma Treatment and Prognosis
article

Fiducial marker–guided microwave ablation of liver tumors occult on conventional ablation-guidance imaging: A prospective single-center technical feasibility study

Soumil Singhal, S K Yadav, Sanjay Saran Baijal, Anubhav Harish Khandelwal, Vinamrita Patni, Gaurav Meel, Malik Faizan Abass
article en

Abstract

Backgrounds/Aims: Some liver tumors are visible on dynamic magnetic resonance imaging (MRI) yet remain occult on ultrasound (US), non-enhanced computed tomography (CT), US-CT/MRI fusion imaging, and contrast-enhanced US, which precludes image-guided ablation. We report a prospective single-center feasibility study of percutaneous gold fiducial tagging undertaken to enable microwave ablation (MWA) of such lesions. Methods: Of 168 patients (204 lesions) referred for hepatic ablation between January 2024 and March 2025, 25 lesions in 20 patients were occult on all four modalities and were enrolled. A single gold fiducial was implanted under US guidance one day before ablation using MRI-derived anatomic landmarks. Post-placement imaging characterized the three-dimensional fiducial-to-lesion offset and thereby provided a calibrated targeting vector for MWA. Technical success was defined as complete lesion coverage with a ≥ 5 mm circumferential margin on post-procedure imaging. Results: All 25 fiducials were placed without complications (median fiducial-to-lesion distance 8 mm, range 2-19). MWA was technically successful in 25 of 25 lesions (100%), and an independently confirmed ≥ 5 mm margin was achieved in every case. No procedure-related complications occurred and no local tumor progression was detected over a median follow-up of 21 months (range 12-30). Conclusions: Percutaneous gold fiducial tagging with vector-guided MWA is a feasible and reproducible strategy for ablating liver tumors that are occult on conventional planning modalities, achieving high targeting reproducibility and early local control in a selected cohort.

Annals of Hepato-Biliary-Pancreatic Surgery
Medanta The Medicity (IN), Medanta The Medicity (IN)
Good health and well-being
Hepatocellular Carcinoma Treatment and Prognosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon